mRNA Vaccines

Regulatory Approval Moderna Moderna mRNA-1010

FDA Panel Weighs Moderna’s Bid for First U.S. mRNA Flu Vaccine

A favorable advisory vote could clear a faster, reformulatable mRNA platform for U.S. use while requiring confirmatory studies to address gaps for older adults.

4 ARTICLES

last yr.

Moderna’s mRNA-1010 Flu Vaccine Outperforms Standard Shot and Advances Toward Approval